Immuno-oncology

RSS

Roche's Roferon-A receives EU approval

March 4, 1997

IGG's MMS-1 covered by patent

March 3, 1997

Immunotherapy cancer vaccine in phase II

Feb. 20, 1997

Encouraging results obtained for immunotoxin in Hodgkin's lymphoma

Feb. 17, 1997

Labeled SMART antibody shows promise for AML treatment

Feb. 17, 1997

Maxim's lead product approaches pivotal trials

Feb. 12, 1997

Genzyme Transgenics reports advances in transgenic production of MAbs

Feb. 11, 1997

Il Yang develops antitumor/immunostimulating proteoglycan

Feb. 7, 1997

AltaRex's lead product given orphan drug status

Jan. 17, 1997

CPMP approves unified labeling for Intron A

Jan. 17, 1997